Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 7—July 2015
Letter

Oligella ureolytica Bacteremia in Elderly Woman, United States

Tristan SimmonsComments to Author , Eryn Fennelly, and David Loughran
Author affiliations: Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table

Documented cases of pathogenic Oligella ureolytica infection*

Year Patient age, y Patient sex Location Culture source Concurrent conditions Urinary disorder Reference†
2014 30 M India Blood Metastatic lung adenocarcinoma Urinary incontinence (3)
2013 Newborn F Turkey Blood None Maternal urine exposure during delivery? (4)
2013 89 M United States Urine Adenocarcinoma of prostate High post void residual (5)
1996 49 F Canada Neck lymph node Non-Hodgkin lymphoma None (6)
1993 40 M United States Blood AIDS, sacral ulcer, diarrhea None (7)

*Some published cases that were believed to be contamination or for which the organisms did not fit the laboratory profile of O. ureolytica were excluded.
†Antimicrobial drug sensitivity has varied among reports; some resistant organisms have been encountered (3–8).

Main Article

References
  1. Rossau  R, Kersters  K, Falsen  E, Jantzen  E, Segers  P, Union  A, Oligella, a new genus including Oligella urethralis comb. nov. (formerly Moraxella urethralis) and Oligella ureolytica sp. nov. (formerly CDC group IVe): relationship to Taylorella equigenitalis and related taxa. Int J Syst Evol Microbiol. 1987;37:198–210. DOIGoogle Scholar
  2. Steinberg  JP, Burd  EM. Other gram-negative and gram-variable bacilli. In: Bennett J, Dolin R, Blaser M, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier; 2015. p. 2667–83.
  3. Baruah  FK, Jain  M, Lodha  M, Grover  RK. Blood stream infection by an emerging pathogen Oligella ureolytica in a cancer patient: case report and review of literature. Indian J Pathol Microbiol. 2014;57:141–3. DOIPubMedGoogle Scholar
  4. Demir  T, Celenk  N. Bloodstream infection with Oligella ureolytica in a newborn infant: a case report and review of literature. J Infect Dev Ctries. 2014;8:793–5. DOIPubMedGoogle Scholar
  5. Dabkowski  J, Dodds  P, Hughes  K, Bush  M. A persistent, symptomatic urinary tract infection with multiple “negative” urine cultures. Conn Med. 2013;77:27–9.PubMedGoogle Scholar
  6. Baqi  M, Mazzulli  T. Oligella infections: case report and review of the literature. Can J Infect Dis. 1996;7:377–9.PubMedGoogle Scholar
  7. Manian  FA. Bloodstream infection with Oligella ureolytica, Candida krusei, and Bacteroides species in a patient with AIDS. Clin Infect Dis. 1993;17:290–1. DOIPubMedGoogle Scholar
  8. Welch  WD, Porschen  RK, Luttrell  B. Minimal inhibitory concentrations of 19 antimicrobial agents for 96 clinical isolates of group IVe bacteria. Antimicrob Agents Chemother. 1983;24:432–3. DOIPubMedGoogle Scholar
  9. Klinger  JD, Thomassen  MJ. Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis. 1985;3:149–58. DOIPubMedGoogle Scholar
  10. Winn  WC, Allen  SD, Janda  WM, Koneman  EW, Procop  GW, Schreckenberger  PC, Woods  GL. The nonfermentative gram-negative bacilli. In: Koneman EW, editor. Koneman’s color atlas and textbook of diagnostic microbiology. 6th ed. Washington (DC): Lippincott Williams & Wilkins; 2005. p. 303-91.

Main Article

Page created: June 16, 2015
Page updated: June 16, 2015
Page reviewed: June 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external